Australian anti-trust watchdog loses appeal against Pfizer over Lipitor sales

MELBOURNE (Reuters) – An Australian court dismissed an appeal by the nation’s anti-trust watchdog in a case against Pfizer Inc in which the regulator alleged the company had used its market power to limit competition for its cholesterol-lowering drug Lipitor.

Source: Reuters Health